Tupperware Heights: Apartments and more proposed near SunRail station
A New York-based firm is planning a major mixed-use development near a SunRail station, potentially bringing hundreds of new apartments to the area.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Knicks rumors: Bill Simmons floats Kevin Durant trade proposal
The post Knicks rumors: Bill Simmons floats Kevin Durant trade proposal appeared first on ClutchPoints. After the New York Knicks lost in the Eastern Conference Finals to the Indiana Pacers in six games, the focus now is an analysis on how they can improve going into the offseason. With the Knicks already surrounded by rumors, Bill Simmons would have an interesting trade proposal that is sure to have fans possibly scratching their heads. Advertisement His trade surrounds star Karl-Anthony Towns, where he would say a one-for-one deal where he is sent to the Phoenix Suns for forward Kevin Durant. Simmons would point to the connection between Towns and Suns guard Devin Booker and how they have 'known each other since they were kids.' 'Let me throw this one at you, Towns for Durant,' Simmons said on his self-titled show. 'I think Durant has a year left, but you can extend him. The salaries actually work as a one-for-one. Towns, if you remember, has a whole friendship history with Booker. Like they've known each other since they were kids, they have the same agent. I remember we got pitched this at The Ringer in 2019. Towns, Booker, and Russell all wanted to do a podcast together, and they all lived in different places, and we were like, there's no way. Like now we would have the technology.' Bill Simmons further explains how the Knicks can get Kevin Durant Kirby Lee-Imagn Images While fans have already made some trade proposals with the Knicks star in Towns, this one returns an elite player like Durant, though it would be understood that he's in the twilight years of his career. Simmons would argue that it's almost a win-win scenario for each team as Phoenix gets back a highly productive player in Towns and New York gets an impact player in Durant. Advertisement 'If they don't have a ton of outs with Durant, and if you're the Suns, you don't have a lot of ways to get better,' Simmons said. 'If Booker loves Towns, and I think they're still buddies, is that a way to get out of the Durant business. Then, if you're the Knicks, you have this one-year run with Durant. You can talk yourself into Mitchell Robinson 30 minutes a game. You're out of the Towns' defense business; you kind of sold high. You got out of Randle, you got out of Towns with this big contract coming.' Last season in his first with the Knicks, Towns averaged 24.4 points, 12.8 rebounds, and 3.1 assists per game while shooting 52.6 percent from the field and 42 percent from beyond the arc. It remains to be seen what happens with Towns, but New York looks to improve after losing to Indiana in the Eastern Conference Finals.
Yahoo
35 minutes ago
- Yahoo
Draymond Green doubts Knicks can win title without ‘great player'
The post Draymond Green doubts Knicks can win title without 'great player' appeared first on ClutchPoints. Golden State Warriors forward Draymond Green cast doubt on the New York Knicks' championship outlook in the aftermath of their Eastern Conference Finals exit, emphasizing the need for a true star to lead the franchise to a title. Advertisement Green addressed the Knicks' future on a recent episode of The Draymond Green Show, stating bluntly that New York is still not equipped to win it all. 'As far as the Knicks going forward, I think going forward in order to win it ain't there yet,' Green said. 'I just don't foresee it. I think in order to win the Knicks need to bring in a great player. I can't talk specific names because I'm not going to give my money away for that, but if the Knicks want to compete for a championship I think they need a great player.' The comments follow the Knicks' elimination by the Indiana Pacers in six games, cutting short a postseason run that saw the franchise reach the Eastern Conference Finals for the first time since 2000. Despite making key additions last offseason — most notably Mikal Bridges and Karl-Anthony Towns — New York ultimately fell short in its bid to return to the NBA Finals. Despite Jalen Brunson's playoff brilliance, Draymond Green says Knicks need a 'great player' Trevor Ruszkowski-Imagn Images Jalen Brunson once again delivered an elite postseason performance. The All-NBA guard averaged 29.4 points, seven assists and 3.4 rebounds while shooting 46.1% from the field and 35.8% from three-point range across 18 games. He played 37.8 minutes per contest and carried much of the offensive load. Advertisement Still, the absence of another top-tier shot creator or All-NBA-caliber star appeared to loom large in the series loss to Indiana. In the aftermath of the season-ending defeat, ESPN's Shams Charania reported on SportsCenter that the Knicks are conducting internal meetings this week to evaluate their path forward. 'I'm told the Knicks have internal meetings this week to really evaluate everything from their coaches to their players and just see how they move forward to continue to compete for a championship in the Eastern Conference,' Charania said. 'But if we've seen the last year and a half as any indication, for Leon Rose, the Knicks president, went out and got OG Anunoby, Mikal Bridges, and Karl-Anthony Towns to elevate this team. I do expect the Knicks to be aggressive to see, is there a move out there, a landmark move, potentially, that takes this team over the top, or do they just make moves around the edges for their bench?' Knicks part ways with Tom Thibodeau as pursuit of star talent like Giannis or Durant looms New York has already made a significant change, firing head coach Tom Thibodeau on Tuesday, according to Charania. Thibodeau, hired ahead of the 2020-21 season, led the team to four playoff appearances in five years, missing only in 2021-22. Advertisement Ian Begley of SNY reported that the organization holds 'great respect for Thibodeau and what he did for [the] Knicks, but simply felt a new voice was needed.' The Knicks have been linked to potential trade pursuits of Milwaukee Bucks forward Giannis Antetokounmpo and Phoenix Suns star Kevin Durant. As the team prepares for the 2025-26 season, Green's remarks reflect a broader belief that one more elite player may be the missing piece.
Miami Herald
an hour ago
- Miami Herald
Major healthcare business files for Chapter 11 bankruptcy
Biotechnology companies often encounter common challenges of long timelines for developing their products, the high costs associated with creating their innovations, and regulatory problems that must be solved to bring their inventions to market. Companies will amass huge amounts of debt over the years that's needed to develop medical devices, drugs, and other products, which can lead to financial distress and sometimes bankruptcy filings. Don't miss the move: Subscribe to TheStreet's free daily newsletter Over a 12-year period from 2011 through 2022, biotech firms filed fewer than 10 bankruptcies each year, but that changed beginning in 2023. Related: Key healthcare company files for Chapter 11 bankruptcy Biotech firms filed 14 cases in 2023, which was the highest number since 2010, when 14 firms filed for bankruptcy. Companies filed 13 petitions in 2024. Economic issues common to all businesses, such as rising costs of labor and products driven by inflation and rising inflation, played a role in distress over the last two years. AmplifyBio, which develops next-generation vaccines, medicine, and therapeutics, filed for Chapter 11 protection on May 17, 2025, seeking to sell all of its assets and liquidate through the bankruptcy process. The debtor's largest creditors included certain shareholders, including Battelle Services Co., owed $3.25 million; Battelle Memorial Institute, owed $1.89 million; and Kavra 14 LLC, owed $1.8 million. Distressed biotechnology company Synthego Corp. filed for Chapter 11 bankruptcy protection on May 5, seeking to sell its assets to its prepetition lender Perceptive Credit Holdings III L.P. in a bankruptcy sale with a stalking-horse bid calling for a credit bid of $74.4 million of debt owed to the lender, as well as a $12.5 million DIP financing. Austin, Texas-based biotechnology company Molecular Templates Inc., which develops cancer treatment drugs, filed for Chapter 11 bankruptcy on April 20, 2025, with plans to hand its assets to its secured lender as part of a restructuring support agreement. And now, medical diagnostics company Capture Collective Inc., which is developing and commercializing medical testing equipment for early detection of radiation exposure, and two affiliates, filed for Chapter 11 bankruptcy protection on May 27 to reorganize their debts, facing high litigation costs. Related: Major health care company files for bankruptcy to sell assets The company listed $1 million to $10 million in assets and liabilities in its petition filed in the U.S. Bankruptcy Court for the Southern District of Ohio, including a $5.7 million disputed tax claim owed to its largest creditor Hawaii Department of Taxation. More bankruptcy: Iconic auto repair chain franchise files Chapter 11 bankruptcyPopular beer brand closes down and files Chapter 7 bankruptcyPopular vodka and gin brand files for Chapter 11 bankruptcy The Columbus, Ohio-based debtor and affiliates Capture Diagnostics LLC and Capture Diagnostics HIB01 had also faced costly contract disputes as a result of its Covid-19 testing business that ceased operations in May 2023. Capture Collective was unable to resolve the contract disputes with claimants after the Covid-19 testing business ended. The company said high litigation costs had exhausted all of its remaining capital resources and made it impossible for the company to obtain new venture capital, according to information provided by RK Consultants. All litigation filed against Capture Collective and its affiliates is subject to an automatic stay while the bankruptcy case proceeds. Capture Collective is developing the radiation biodosimetry diagnostic test, MiRAD, a high-throughput, microRNA biomarker-based biodosimetry assay, which enables individualized clinical biomarker quantification in direct correlation with radiation exposure. Related: Another major healthcare company files Chapter 11 bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
